|
|
|
|
LEADER |
00000cam a22000001i 4500 |
001 |
SCIDIR_on1124520675 |
003 |
OCoLC |
005 |
20231120010416.0 |
006 |
m d |
007 |
cr ||||||||||| |
008 |
190910s2019 ne o 000 0 eng d |
040 |
|
|
|a UKMGB
|b eng
|e rda
|e pn
|c UKMGB
|d OCLCO
|d UKAHL
|d OCLCF
|d OPELS
|d N$T
|d SNM
|d ABC
|d OCLCO
|d OCLCA
|d OCLCO
|d K6U
|d OCLCQ
|d OCL
|d OCLCO
|
015 |
|
|
|a GBB9F9520
|2 bnb
|
016 |
7 |
|
|a 019546597
|2 Uk
|
019 |
|
|
|a 1124446114
|
020 |
|
|
|a 0128158506
|
020 |
|
|
|a 0128158492
|
020 |
|
|
|a 9780128158494
|
020 |
|
|
|a 9780128158500
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)1124520675
|z (OCoLC)1124446114
|
050 |
|
4 |
|a RM301.9
|b .d37 2019
|
082 |
0 |
4 |
|a 615.7
|2 23
|
100 |
1 |
|
|a Dasgupta, Amitava,
|d 1958-
|e author.
|
245 |
1 |
0 |
|a Therapeutic drug monitoring data :
|b a concise guide /
|c Amitava Dasgupta, Matthew Krasowski.
|
250 |
|
|
|a 4th.
|
264 |
|
1 |
|a Amsterdam :
|b Academic Press,
|c 2019.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|2 rdacontent
|
337 |
|
|
|a computer
|2 rdamedia
|
338 |
|
|
|a online resource
|2 rdacarrier
|
505 |
0 |
|
|a 1. Pharmacokinetics and Therapeutic Drug Monitoring<br>2. Before and After: The Preanalytical and Postanalytical Phases of Therapeutic Drug Monitoring<br>3. Clinical Utility of Monitoring Free Drug Concentrations<br>4. Effect of Bilirubin, Lipemia, Hemolysis, Paraproteins, and Heterophilic Antibodies on Immunoassays for Therapeutic Drug Monitoring<br>5. Drug-Herb and Drug-Food Interactions and Effects on Therapeutic Drug Monitoring<br>6. Monitoring Anticonvulsant Concentrations -- General Considerations<br>7. Therapeutic Drug Monitoring of Cardioactive Drugs<br>8. Therapeutic Drug Monitoring of Antidepressants<br>9. Introduction to Immunosuppressive Drug Monitoring<br>10. Therapeutic Drug Monitoring of Antimicrobial and Antiviral Agents<br>11. Therapeutic Drug Monitoring of Analgesics<br>12. Therapeutic Drug Monitoring of Antineoplastic Drugs<br>13. Caffeine, Lithium, and Theophylline
|
588 |
|
|
|a Description based on CIP data; resource not viewed.
|
520 |
|
|
|a Therapeutic Drug Monitoring Data: A Concise Guide, Fourth Edition serves as a ready resource of information on commonly monitored drugs that will help readers make decisions relating to the monitoring and interpretation of results. It is an easy-to-read source of information on intended use, pharmacokinetics, therapeutic range, and toxic concentrations, as well as bioavailability, disposition, metabolism and the excretion of commonly monitored therapeutic drugs. This fully updated fourth edition includes sections on new anticonvulsants, anti-depressant and anti-HIV drugs, new drugs for advanced cancer treatment, and thoroughly updated chapters that address new pitfalls and problems in the lab.
|
650 |
|
0 |
|a Drug monitoring.
|
650 |
|
0 |
|a Pharmacovigilance.
|
650 |
|
0 |
|a Drugs
|x Side effects
|x Reporting.
|
650 |
|
0 |
|a Drugs.
|
650 |
1 |
2 |
|a Drug Monitoring
|0 (DNLM)D016903
|
650 |
2 |
2 |
|a Pharmaceutical Preparations
|0 (DNLM)D004364
|
650 |
|
2 |
|a Product Surveillance, Postmarketing
|0 (DNLM)D011358
|
650 |
|
2 |
|a Pharmacovigilance
|0 (DNLM)D060735
|
650 |
|
6 |
|a Pharmacovigilance.
|0 (CaQQLa)201-0217159
|
650 |
|
6 |
|a M�edicaments.
|0 (CaQQLa)201-0002990
|
650 |
|
7 |
|a Pharmacovigilance
|2 fast
|0 (OCoLC)fst02002642
|
650 |
|
7 |
|a Drugs
|x Side effects
|x Reporting
|2 fast
|0 (OCoLC)fst00898914
|
650 |
|
7 |
|a Drugs
|2 fast
|0 (OCoLC)fst00898761
|
650 |
|
7 |
|a Drug monitoring
|2 fast
|0 (OCoLC)fst00898688
|
700 |
1 |
|
|a Krasowski, Matthew D.,
|e author.
|
776 |
0 |
8 |
|i Print version:
|z 9780128158494
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128158494
|z Texto completo
|